Dataset from A Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild-to-Moderate Alzheimer's Disease

Name: Dataset from A Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild-to-Moderate Alzheimer's Disease
Creator: 暂无描述
License: 暂无描述

NIAID Data Ecosystem2026-05-02 收录

下载链接：

https://doi.org/10.25934/PR00008378

下载链接

链接失效反馈

官方服务：

资源简介：

This is a efficacy and safety study evaluating new treatment for subjects with mild to moderate Alzheimer's Disease.

创建时间：

2024-11-26